CHRISTOPHER J. TWOMEY - 22 May 2024 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
Director
Signature
/s/ Rachel Malina, Attorney-in-Fact for Christopher J. Twomey
Issuer symbol
TNDM
Transactions as of
22 May 2024
Net transactions value
+$229,371
Form type
4
Filing time
24 May 2024, 19:22:45 UTC
Previous filing
16 Jun 2023
Next filing
20 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $229,371 +4,434 +65% $51.73 11,288 24 May 2024 Direct
holding TNDM Common Stock 5,112 22 May 2024 See Footnote F1
holding TNDM Common Stock 7,568 22 May 2024 See Footnotes F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Award $0 +4,387 $0.000000 4,387 22 May 2024 Common Stock 4,387 Direct F3, F4, F5
transaction TNDM Restricted Stock Unit Options Exercise $0 -4,434 -100% $0.000000* 0 24 May 2024 Common Stock 4,434 Direct F4, F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by the Chris J. Twomey and Rebecca J. Twomey Family Trust UTD September 20, 2002.
F2 The securities are directly owned by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over these securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.
F3 Awarded on May 22, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan).
F4 Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F5 RSU will vest on the one-year anniversary of the grant date, subject to the terms of the 2023 Plan.
F6 Awarded on May 24, 2023 pursuant to the 2023 Plan.